# Neurocrine Biosciences, Inc. (NBIX): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/nbix for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Neurocrine Biosciences, Inc. is a pharmaceutical firm dedicated to the creation, advancement, and commercialization of medicines addressing a spectrum of neurological, endocrine, and psychiatric conditions. Its current therapeutic pipeline and marketed products target disorders such as tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, alongside numerous experimental compounds in various clinical stages. The company's primary commercial asset is INGREZZA, a VMAT2 inhibitor indicated for the management of tardive dyskinesia. Other available treatments include ONGEN...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $142.70 USD |
| Market Cap | $14.51B |
| P/E (TTM) | 16.44 |
| EPS (TTM) | $8.68 |
| 52-Week Range | $122.14 – $186.12 |
| Dividend Yield (TTM) | — |

## Dividend

NBIX has no dividend payment history in our records.

## Frequently Asked Questions

### What does Neurocrine Biosciences, Inc. do?

Neurocrine Biosciences, Inc. (NBIX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is NBIX's market cap?

Neurocrine Biosciences, Inc. (NBIX) has a market capitalization of approximately $14.51 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does NBIX pay a dividend?

No, Neurocrine Biosciences, Inc. (NBIX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Has NBIX ever paid a dividend?

No. Dividend Data's records show no dividend payments from Neurocrine Biosciences, Inc. (NBIX). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/nbix
- Dividend history & safety: https://www.dividenddata.com/stocks/nbix/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/nbix/earnings
- Financial statements: https://www.dividenddata.com/stocks/nbix/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/nbix/valuation
- Peer comparison: https://www.dividenddata.com/stocks/nbix/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.